Penn Medicine has partnered with Mark Cuban’s Cost Plus Drug Company through its innovative Cost Plus Marketplace in a strategic alliance that will allow Penn Medicine to secure the top 100 most frequently dispensed generic drugs–such as antibiotics, cancer treatments, blood thinners, and asthma medications–from the company for the health system’s vast retail pharmacy network, which fills over 1.5 million prescriptions annually across 16 locations.
